CCG 203769
CCG 203769 is a selective G protein signaling (RGS4) inhibitor, which blocks the RGS4-Gαo protein-protein interaction in vitro with an IC50 of 17 nM.
Product Specifications
CAS Number
[410074-60-1]
UNSPSC
12352005
Target
RGS Protein
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/CCG_203769.html
Purity
99.76
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(N1CCCC)N(CC)SC1=O
Molecular Formula
C8H14N2O2S
Molecular Weight
202.27
References & Citations
[1]Blazer LL, et al. Selectivity and anti-Parkinson's potential of thiadiazolidinone RGS4 inhibitors. ACS Chem Neurosci. 2015 Jun 17;6 (6) :911-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
RGS16; RGS19; RGS4; RGS8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
148954 100 µg
P2RY1, Control Peptide (P2Y Purinoceptor 1, P2Y1, ATP Receptor, Purinergic Receptor) discontinued
Ask
View Details 
MBS1381883-01 0.02 mg (E-Coli)
Recombinant Rhizobium meliloti Xylose isomerase (xylA)
Ask
View Details MBS1381883-02 0.02 mg (Yeast)
Recombinant Rhizobium meliloti Xylose isomerase (xylA)
Ask
View Details MBS1381883-03 0.1 mg (E-Coli)
Recombinant Rhizobium meliloti Xylose isomerase (xylA)
Ask
View Details MBS1381883-04 0.1 mg (Yeast)
Recombinant Rhizobium meliloti Xylose isomerase (xylA)
Ask
View Details